Postoperative Bleeding Risk after Gastric Endoscopic Submucosal Dissection in Patients Receiving a P2Y12 Receptor Antagonist.
Ryosuke HiraiKawano SeijiShoko InooSakiko KuraokaShotaro OkanoueTakuya SatomiKenta HamadaYoshiyasu KonoHiromitsu KanzakiIwamuro MasayaYoshiro KawaharaHiroyuki OkadaPublished in: Gut and liver (2022)
P2Y12RA use is a risk factor for postoperative bleeding in patients who undergo ESD even if receiving drug management according to guidelines. Dual antiplatelet therapy carries a higher risk of bleeding than monotherapy.
Keyphrases
- endoscopic submucosal dissection
- antiplatelet therapy
- atrial fibrillation
- percutaneous coronary intervention
- acute coronary syndrome
- patients undergoing
- rheumatoid arthritis
- combination therapy
- open label
- clinical practice
- randomized controlled trial
- emergency department
- coronary artery disease
- ankylosing spondylitis